Watchlist Price Alert

Syros Pharmaceuticals Inc... (SYRS)

NASDAQ: SYRS · Real-Time Price · USD

0.03

-0.00 (-3.23%)

At close: May 06, 2025, 3:15 PM

Syros Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-164.57M	-94.65M	-86.56M	-84.04M	-75.44M	-62.28M	-54.01M	-47.74M
Depreciation & Amortization	2.25M	2.97M	3.02M	3.04M	2.72M	1.6M	1.53M	1.27M
Stock-Based Compensation	10.43M	11.41M	10.35M	10.94M	9.84M	6.61M	4.42M	4.23M
Other Working Capital	-1.77M	-8.28M	-12.64M	-6.35M	19.54M	13.5M	-870K	-284K
Other Non-Cash Items	37.13M	-37.27M	706K	2.32M	7.24M	-642K	-102K	10K
Deferred Income Tax	n/a	n/a	-16.46M	326K	-1.13M	n/a	n/a	n/a
Change in Working Capital	5.05M	-5.52M	-10.6M	10.05M	-3.48M	14.39M	3.44M	1.69M
Operating Cash Flow	-109.71M	-123.06M	-99.54M	-57.36M	-60.25M	-40.31M	-44.73M	-40.54M
Capital Expenditures	-272K	-1.24M	-1.25M	-3.34M	-12.64M	-1.38M	-821K	-2.32M
Cash Acquisitions	n/a	n/a	n/a	n/a	110K	9K	n/a	n/a
Purchase of Investments	-50.97M	n/a	-51.41M	n/a	-108.21M	-96.77M	-41.77M	-25.02M
Sales Maturities Of Investments	87.02M	68.43M	n/a	50M	109M	87.5M	27M	n/a
Other Investing Acitivies	1.56M	68.43M	-51.41M	50M	904K	9K	-14.77M	-25.02M
Investing Cash Flow	37.34M	67.19M	-52.65M	46.66M	-11.73M	-10.64M	-15.59M	-27.34M
Debt Repayment	-65K	-291K	-265K	39.38M	-205K	-50K	-168K	-135K
Common Stock Repurchased	n/a	-81K	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	257K	11.66M	439K	1.3M	374K	626K	1.8M	395K
Financial Cash Flow	43.46M	131.04M	70.51M	142.95M	65.99M	69.08M	33.94M	90.56M
Net Cash Flow	-28.91M	75.17M	-81.68M	132.25M	-6M	18.13M	-26.38M	22.68M
Free Cash Flow	-109.98M	-124.31M	-100.78M	-60.7M	-72.89M	-41.7M	-45.55M	-42.86M